Clinical Trial Update: A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency [Phase 3]

View source ↗

Summary

Phase 3 open-label safety trial of SA-001 in pancreatic exocrine insufficiency has completed, assessing long-term oral safety. The study included participants w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatectomy
• Pancreatic Exocrine Insufficiency
• Pancreatitis

Drugs mentioned

• SA-001

Snippet

Sponsor: Abbott | Conditions: Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy | Phase 3 | Status: COMPLETED